http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101316095-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2250-2124 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-322 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-258 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-30 |
| filingDate | 2013-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101316095-B1 |
| titleOfInvention | A composition for the prevention and treatment of neuropathic pain, comprising ginsenosides R1 and R3, COM3, COM, and ginseng-derived saponin extracts as active ingredients |
| abstract | The present invention relates to a composition for preventing and treating neuropathic pain containing ginsenosides Rb1 and Rg3, Compound K, or ginseng-derived saponin extract as an active ingredient, specifically, ginsenosides Rb1 and Rg3, Compound K, or Ginseng-derived saponin extracts have been shown to inhibit the pain caused by central nerve damage, peripheral nerve damage, and inflammation. These pain-inhibiting effects are mediated by estrogen receptors and also pain-related factors in the spinal cord microglial cells. It acts by inhibiting expression. |
| priorityDate | 2013-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 106.